Vashisht Rishik, Mirzai Saeid, Koval Christine, Duggal Abhijit
Department of Critical Care, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Department of Medicine, Alabama College of Osteopathic Medicine, Dothan, Alabama, USA.
Indian J Crit Care Med. 2020 May;24(5):367-368. doi: 10.5005/jp-journals-10071-23428.
Viral causes of acute respiratory distress syndrome (ARDS) are mostly limited to influenza A; however, adenovirus has been emerging as a cause of fulminant ARDS with a high mortality rate and no consensus on its management. Here we present a series of five patients with confirmed adenovirus infection treated for ARDS at our quaternary referral institution.
All patients were above 18 years old, had confirmed adenovirus infection, and were treated for acute hypoxic respiratory failure requiring mechanical ventilation in our medical intensive care unit (MICU). Demographic and clinical data were collected and analyzed.
Among these patients, the median age was 28 years, median BMI 28 kg/m median sequential organ failure assessment (SOFA) score 9, and median acute physiology and chronic health evaluation (APACHE) III score 74. All patients received lung-protective mechanical ventilation with high positive end-expiratory pressure and low plateau pressures. Three patients developed severe ARDS, two received prone position ventilation, and one was placed on extracorporeal membrane oxygenation. The median duration of mechanical ventilation, MICU length of stay, and hospital length of stay were 24, 19, and 27 days, respectively. One out of five patients died in our study.
The mortality rate for adenovirus-associated pneumonia in the literature is estimated to be 40% in those requiring mechanical ventilation. The lower mortality at our institution could be attributed to the use of standardized protocols, which include low tidal volume ventilation, early use of neuromuscular blockade, targeting low plateau pressures, conservative fluid management, and comfort and familiarity with the use of adjunctive and rescue therapies. We recommend testing for adenovirus as part of a routine respiratory viral panel in ARDS patients, and if tested positive, transfer to tertiary or quaternary centers with the experience and rescue modalities needed to manage complicated ARDS patients.
Vashisht R, Mirzai S, Koval C, Duggal A. Adenovirus-associated Acute Respiratory Distress Syndrome: Need for a Protocol-based Approach. Indian J Crit Care Med 2020;24(5):367-368.
急性呼吸窘迫综合征(ARDS)的病毒病因大多局限于甲型流感;然而,腺病毒已逐渐成为暴发性ARDS的病因,其死亡率高,且在治疗上尚无共识。在此,我们介绍了在我们的四级转诊机构接受治疗的5例确诊腺病毒感染的ARDS患者。
所有患者年龄均在18岁以上,确诊腺病毒感染,并在我们的医学重症监护病房(MICU)因急性低氧性呼吸衰竭需要机械通气而接受治疗。收集并分析人口统计学和临床数据。
这些患者的中位年龄为28岁,中位体重指数为28kg/m²,中位序贯器官衰竭评估(SOFA)评分为9分,中位急性生理与慢性健康状况评估(APACHE)Ⅲ评分为74分。所有患者均接受了高呼气末正压和低平台压的肺保护性机械通气。3例患者发生了严重ARDS,2例接受了俯卧位通气,1例接受了体外膜肺氧合治疗。机械通气的中位持续时间、MICU住院时间和住院时间分别为24天、19天和27天。本研究中5例患者中有1例死亡。
文献中腺病毒相关肺炎在需要机械通气的患者中的死亡率估计为40%。我们机构较低的死亡率可能归因于使用了标准化方案,包括低潮气量通气、早期使用神经肌肉阻滞剂、设定低平台压、保守的液体管理以及对辅助和挽救治疗的熟练运用。我们建议将腺病毒检测作为ARDS患者常规呼吸道病毒检测的一部分,如果检测呈阳性,应转至具备管理复杂ARDS患者所需经验和挽救措施的三级或四级中心。
Vashisht R, Mirzai S, Koval C, Duggal A. 腺病毒相关急性呼吸窘迫综合征:基于方案治疗的必要性。《印度重症监护医学杂志》2020;24(5):367 - 368。